1. Galie N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A et al (2015) 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: the Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Respir J 37(1):67–119
2. Wilkens H, Konstantinides S, Lang I, Bunck AC, Gerges M, Gerhardt F et al (2016) Chronic thromboembolic pulmonary hypertension: recommendations of the Cologne Consensus Conference 2016. Dtsch Med Wochenschr 141(S01):S62–S69
3. Ulrich S, Fischler M, Speich R, Popov V, Maggiorini M (2006) Chronic thromboembolic and pulmonary arterial hypertension share acute vasoreactivity properties. Chest 130(3):841–846
4. Cenedese E, Speich R, Dorschner L, Ulrich S, Maggiorini M, Jenni R et al (2006) Measurement of quality of life in pulmonary hypertension and its significance. Eur Respir J 28(4):808–815
5. Cannon JE, Pepke-Zaba J (2013) Is distal chronic thromboembolic pulmonary hypertension treatable with PAH targeted drugs? Semin Respir Crit Care Med 34(5):620–626